Tobam decreased its stake in shares of Clorox Company (The) (NYSE:CLX) by 3.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 324,450 shares of the company’s stock after selling 12,203 shares during the period. Clorox Company (The) makes up 1.6% of Tobam’s portfolio, making the stock its 21st largest position. Tobam owned about 0.25% of Clorox Company (The) worth $43,230,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently modified their holdings of the stock. American Beacon Advisors Inc. purchased a new position in shares of Clorox Company (The) during the first quarter valued at approximately $104,000. Parkside Financial Bank & Trust increased its position in shares of Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after buying an additional 29 shares during the period. Valley National Advisers Inc. increased its position in shares of Clorox Company (The) by 0.6% in the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. increased its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares during the period. Finally, Zions Bancorporation increased its position in shares of Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock valued at $134,000 after buying an additional 53 shares during the period. 69.83% of the stock is owned by hedge funds and other institutional investors.

Clorox Company (CLX) opened at 137.48 on Friday. The company’s 50 day moving average is $134.18 and its 200 day moving average is $134.70. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76. The stock has a market cap of $17.74 billion, a PE ratio of 25.77 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last announced its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.04. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The company’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period last year, the firm posted $1.30 earnings per share. On average, analysts anticipate that Clorox Company will post $5.67 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Clorox Company (The) (CLX) Position Decreased by Tobam” was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The correct version of this piece of content can be viewed at https://theolympiareport.com/2017/08/27/clorox-company-the-clx-position-decreased-by-tobam.html.

Several equities analysts have recently commented on CLX shares. Zacks Investment Research raised shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price objective for the company in a research note on Tuesday, July 4th. BMO Capital Markets reaffirmed a “buy” rating and set a $136.00 price objective on shares of Clorox Company (The) in a research note on Thursday, May 4th. Barclays PLC reaffirmed an “equal weight” rating and set a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. Deutsche Bank AG reaffirmed a “hold” rating and set a $137.00 price objective (up from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. Finally, Jefferies Group LLC set a $138.00 price objective on shares of Clorox Company (The) and gave the company a “hold” rating in a research note on Wednesday, May 3rd. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $129.05.

In other news, EVP James E. Foster sold 9,861 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the transaction, the executive vice president now directly owns 22,069 shares in the company, valued at $3,056,777.19. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the transaction, the senior vice president now owns 20,614 shares in the company, valued at $2,862,666.18. The disclosure for this sale can be found here. Company insiders own 0.74% of the company’s stock.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.